Tranq’s dilemma: How to treat addiction and reconstruct limbs at the same time. Philadelphia doctors are figuring it out.
David ‘Lee’ Wells, seen with roommate Stephanie McFadyen, lost five fingers to wounds related to use of fentanyl laced with xylazine.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New drug to treat marijuana addiction proves effective in small trial“This is one of the very few medications that I’ve tested to directly decrease the effects of cannabis,” said the study’s lead author.
Read more »
Pope recovering well from surgery but to skip Sunday blessingPope Francis' recovery from surgery is going well but doctors advised him not to deliver his Sunday blessing from a hospital balcony to avoid strain on his abdomen.
Read more »
Doctors urge Pope Francis to skip public prayer, says pontiff is recovering wellDoctors have urged Pope Francis not to lead his regular Angelus public prayer next week to ensure his recovery continues to go well, the Vatican says.
Read more »
Pope recovering well from surgery but will skip Sunday blessingPope Francis' recovery from surgery is going well but doctors advised him not to deliver his Sunday blessing from a hospital balcony to avoid strain on his abdomen.
Read more »
ChatGPT's responses to suicide, addiction, sexual assault crises raise questions in new studyWhen asked serious public health questions related to abuse, suicide or other medical crises, the online chatbot tool ChatGPT provided critical resources — such as what 1-800 lifeline number to call for help — only about 22% of the time in a new study.
Read more »
Alzheimer's drug gets FDA panel's backing, setting the stage for broader useU.S. health advisers are backing the full approval of an Alzheimer's drug that received preliminary approval last year. A panel of advisers to the Food and Drug Administration on Friday voted in favor of the infused medication from drugmakers Eisai and Biogen. The FDA granted accelerated approval in January based on early results suggesting the drug could modestly slow Alzheimer's. Friday's full-day meeting focused on more recent study results intended to show that the drug clearly benefits patients. A decision from FDA is expected by July 6. It will be significant because insurers have delayed paying for the drug until it has full approval.
Read more »